Quote:
|
Originally Posted by ObieX
This could, hopefully, lead to a change in the way drugs are regulated in this country. Maybe unlikely as a direct result of this case, but it will raise issues that may not go away for a while (and are already on some people's minds).
|
Obie, excellent point, I tried to allude to that, and I think some others have made comments that lead me to believe that if the Court rules for Oregon, depending on how they cite it and how the opinion is written, it could have ramifications for drug policy in many other areas. That the Fed is assuming since it has excercised this power against other drugs and in so many ways before that it is almost taking this power for granted. Should they be denied it, all kinds of drug war tactics and pharmeceutical regulation issues will have to be revisisted, and we may not like all the results. However, I suspect that even if they rule in favor of Oregon, the opinion will be written to avoid this to some degree.